PHYCO-BIOTECH Laboratories is an innovative biotechnology startup based in France, founded in 2011 and is at the cutting edge of Health Research. The company has positioned itself as a leader in microalgae valorization, focusing on optimal quality products. With 25 years of experience in microalgae, particularly cyanobacteria, and research collaborations with INSERM, University of Montpellier, INRA, and CNRS, Phyco-Biotech Laboratories has garnered a strong reputation for expertise in extracting and purifying phycobiliproteins and developing fluorescent labels for medical diagnosis. Additionally, the company produces and markets pharmaceutical products, including innovative natural food supplements for therapeutic purposes, contributing to the advancement of healthcare. With no recent investment disclosures, Phyco-Biotech Laboratories’ notable focus on scientific research and development, along with established collaborations, positions it as a compelling prospect for potential investors in the biotechnology sector.
There is no investment information
No recent news or press coverage available for PHYCO-BIOTECH Laboratories.